The reality is that you have no clue as to what the regulatory agencies will be looking at when approving DCVaxL. And BTW, your Pvalues and HR's were way off base as usual. You excel in circular arguements from your recliner while real physicians and researchers find the TLD for the DCVaxL trial amazing and it will be approved. You can bank on that!
Market Data 
Markets 
AI
